Literature DB >> 1641674

Development and validation of the PCQ: a questionnaire to measure the psychological consequences of screening mammography.

J Cockburn1, T De Luise, S Hurley, K Clover.   

Abstract

We have developed a reliable and valid questionnaire to measure the psychological consequences of screening mammography. The questionnaire measures the effect of screening on an individual's functioning on emotional, social, and physical life domains. Content validity was ensured by extensive review of the relevant literature, discussion with professionals and interviews with attenders at a pilot Breast X-ray Screening Program in Melbourne, Australia. Discriminant validity was assessed by having expert judges sort items into dimensions which they appeared to be measuring. Acceptable levels of concordance (above 80%) with a priori classifications were found. Concurrent validity was demonstrated by comparison of subscale scores of 53 attenders at the Breast X-ray Program with an independent interview assessment of dysfunction on each of the emotional, social and physical dimensions. There was over 79% agreement between interview scores and questionnaire scores for each dimension. Construct validity was confirmed by showing that subscale scores varied in predicted ways. For women who were recalled for further investigation, scores on each subscale measuring negative consequences, were higher at the recall clinic than at screening clinic (emotional: t = -7.28; df = 70; P less than 0.001; physical: t = -2.53; df = 70; P = 0.014; social: t = -2.49; df = 70; P = 0.015). The internal consistency of all subscales was found to be acceptable. This questionnaire is potentially useful for assessing the psychological consequences of the screening process and should have wide application.

Entities:  

Mesh:

Year:  1992        PMID: 1641674     DOI: 10.1016/0277-9536(92)90286-y

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  36 in total

1.  Psychological distress, social withdrawal, and coping following receipt of an abnormal mammogram among different ethnicities: a mediation model.

Authors:  Yamile Molina; Shirley A A Beresford; Noah Espinoza; Beti Thompson
Journal:  Oncol Nurs Forum       Date:  2014-09       Impact factor: 2.172

2.  Measuring psychological consequences of screening: adaptation of the psychological consequences questionnaire into Dutch.

Authors:  A J Rijnsburger; M L Essink-Bot; E van As; J Cockburn; H J de Koning
Journal:  Qual Life Res       Date:  2006-06       Impact factor: 4.147

3.  The Burden of Cystoscopic Bladder Cancer Surveillance: Anxiety, Discomfort, and Patient Preferences for Decision Making.

Authors:  Kevin Koo; Lisa Zubkoff; Brenda E Sirovich; Philip P Goodney; Douglas J Robertson; John D Seigne; Florian R Schroeck
Journal:  Urology       Date:  2017-07-21       Impact factor: 2.649

4.  Influences of race and breast density on related cognitive and emotion outcomes before mandated breast density notification.

Authors:  Mark Manning; Terrance L Albrecht; Zeynep Yilmaz-Saab; Julie Shultz; Kristen Purrington
Journal:  Soc Sci Med       Date:  2016-10-10       Impact factor: 4.634

5.  Demographic, clinical, dispositional, and social-environmental characteristics associated with psychological response to a false positive ovarian cancer screening test: a longitudinal study.

Authors:  Amanda T Wiggins; Edward J Pavlik; Michael A Andrykowski
Journal:  J Behav Med       Date:  2017-10-25

6.  Mammography: influence of departmental practice and women's characteristics on patient satisfaction: comparison of six departments in Norway.

Authors:  K Løken; S Steine; E Laerum
Journal:  Qual Health Care       Date:  1998-09

7.  Affective, cognitive and behavioral outcomes associated with a false positive ovarian cancer screening test result.

Authors:  Amanda T Wiggins; Edward J Pavlik; Michael A Andrykowski
Journal:  J Behav Med       Date:  2017-04-21

8.  CT scan screening is associated with increased distress among subjects of the APExS.

Authors:  Christophe Paris; Marion Maurel; Amandine Luc; Audrey Stoufflet; Jean-Claude Pairon; Marc Letourneux
Journal:  BMC Public Health       Date:  2010-10-26       Impact factor: 3.295

9.  Psychological impact of von Hippel-Lindau genetic screening in patients with a previous history of hemangioblastoma of the central nervous system.

Authors:  Claire Rochette; Karine Baumstarck; Hélène Canoni-Zattara; Ahmad Esmaeel Abdullah; Dominique Figarella-Branger; Morgane Pertuit; Anne Barlier; Frédéric Castinetti; Karel Pacak; Philippe Metellus; David Taïeb
Journal:  J Psychosoc Oncol       Date:  2018-05-15

10.  Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands.

Authors:  Maaike J Denters; Marije Deutekom; Paul Fockens; Patrick M M Bossuyt; Evelien Dekker
Journal:  BMC Gastroenterol       Date:  2009-04-24       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.